Why Jupiter Wellness Stock Is Getting Hammered
Jupiter Wellness Inc (NASDAQ: JUPW) shares are trading lower by 39.10% to $0.62 Thursday morning after the company announced a $4.1 million registered direct offering and private placement.
Reported Late Wednesday, Olink Holding AB (Publ) Announces Pricing Of Public Offering Of 5,831,028 American Depositary Shares At A Price Of $20/ADS
Olink Holding AB (publ) (NASDAQ:OLK) ("Olink" or the "Company"), today announced the pricing of a public offering of 5,831,028 American Depositary Shares, each representing one common share of
Reported Late Wednesday, Bluebird Bio Announces Pricing Of $120M Public Offering Of 20M Shares Of Common Stock At A Price Of $6/Share
bluebird bio, Inc. (NASDAQ:BLUE) ("bluebird") today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $6.00 per share,
Olink Holding AB (publ) Launches Public Offering Of 5,831,028 American Depositary Shares
Olink Holding AB (publ) (NASDAQ:OLK) ("Olink" or the "Company"), today announced the launch of a public offering of 5,831,028 American Depositary Shares, each representing one common share of the
Bit Brother Plunges After $7.1M Equity Offering
Bit Brother Ltd (NASDAQ:BTB) said it has entered into a securities purchase agreement with certain accredited investors to sell $7.1 million…
Arcimoto Nosedives Following $12M Equity Offering
Arcimoto Inc (NASDAQ:FUV) has priced its previously announced public offering of 4 million shares and warrants to purchase up to 4…
Carvana Adopts ‘Poison Pill’ To Avoid Hostile Takeover, Reduce Tax Bill; To Sell Up To $4B Auto Loans
Carvana Co (NYSE:CVNA) adopted a shareholder rights plan to protect long-term shareholder value by preserving the availability of net…
Reported Late Tuesday, Fulcrum Therapeutics Announces Pricing Of $125M Upsized Public Offering Of 9,615,384 Shares Of Common Stock At A Price Of $13/Share
Fulcrum Therapeutics, Inc. ® (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the pricing of